FDA scientists from across the agency have given presentations on topics related to advancing alternative methods. The list below is current and updated regularly.
Perspectives on Evaluating New Tools for Regulatory Use, given by Donna L. Mendrick, PhD
at the DIA 2022 session: The Translational Value of Animal Models in Rare Diseases on June 20, 2022
Advancing Alternative Methods for Regulatory Use, given by David Strauss, MD, PhD
at the FDA Science Board on June 14, 2022
Advancing Alternatives at FDA, given by Donna L. Mendrick, Ph.D.
at the IUTOX panel discussion at the Society of Toxicology Annual Meeting on March 16, 2021
Predicting the Effects of Candidate Drugs: The Future, given by Janet Woodcock, M.D.
Nov. 18, 2020 at the American College of Toxicology Annual Meeting
Resources for You